P. Dieringer
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in ⓘ
-
- Prostate Cancer Treatment and Research 9
- Prostate Cancer Diagnosis and Treatment 4
- Renal cell carcinoma treatment 2
-
- Oral Health Pathology and Treatment 1
- Co-authors
- Christopher J. Logothetis (6 shared papers)Lance C. Pagliaro (5 shared papers)Juan Herrada (2 shared papers)Danai Daliani (4 shared papers)Christos N. Papandreou (3 shared papers)Randall E. Millikan (2 shared papers)Julian Adams (2 shared papers)Shi‐Ming Tu (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (1 paper)The Journal of Urology (1 paper)Prostate Cancer and Prostatic Diseases (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
P. Dieringer
10 papers receiving 489 citations
Peers
Comparison fields: 5 of 59
- Hematology 150
- Oncology 203
- Cancer Research 76
- Pulmonary and Respiratory Medicine 158
- Molecular Biology 299
Countries citing papers authored by P. Dieringer
This map shows the geographic impact of P. Dieringer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Dieringer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Dieringer more than expected).
Fields of papers citing papers by P. Dieringer
This network shows the impact of papers produced by P. Dieringer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Dieringer. The network helps show where P. Dieringer may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Dieringer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 372 | |
| 2 | Characterization of patients with androgen-independent prostatic carcinoma whose serum prostate specific antigen decreased following flutamide withdrawal. | 1996 | 39 |
| 3 | 1996 | 37 | |
| 4 | 2001 | 16 | |
| 5 | 2006 | 10 | |
| 6 | 2006 | 10 | |
| 7 | 2015 | 6 | |
| 8 | 2011 | 5 | |
| 9 | 2008 | 5 | |
| 10 | 2003 | 1 |
About P. Dieringer
P. Dieringer is a scholar working on Pulmonary and Respiratory Medicine, Periodontics, Oncology, Rheumatology and Hematology, having authored 10 papers that have together received 501 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cancer Treatment and Pharmacology (4 papers), Prostate Cancer Diagnosis and Treatment (4 papers), Urologic and reproductive health conditions (2 papers), Ubiquitin and proteasome pathways (2 papers), Renal cell carcinoma treatment (2 papers), Oral Health Pathology and Treatment (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Hematology (150 citations), Oncology (203 citations), Cancer Research (76 citations), Pulmonary and Respiratory Medicine (158 citations) and Molecular Biology (299 citations). P. Dieringer has collaborated with scholars based in United States and Spain. Frequent co-authors include Christopher J. Logothetis, Lance C. Pagliaro, Juan Herrada, Danai Daliani, Christos N. Papandreou, Randall E. Millikan, Julian Adams, Shi‐Ming Tu, Timothy Madden and Jeri Kim. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Journal of Urology, Prostate Cancer and Prostatic Diseases and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.